XGENE BIOTECHNOLOGY COMPANY LIMITED
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Xgene’s key products are clinical-stage analgesic candidates, including oral dual‑mechanism conjugates and topical gels, designed to enhance efficacy and safety through multimodal mechanisms and high target specificity.
Founded Year
2015
Unified Business No.
42836798
Status
Active
Number of Employees
0
Total Paid-in
Capital
100,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Xgene Pharmaceutical Inc. is an innovative biotech company focused on neurological disorders and pain management, using proprietary linker technology to develop dual‑acting prodrugs aimed at safer and more effective next‑generation analgesic therapies.
